http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007184499-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa59c3feb56c9fc7e2a1886871131806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3582444db04bb90d61d13221a343b3c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-76 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2004-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9921a45a1e2924050c98efc697ae43c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_563f96ac1fcfe7dc86fa1838ed521021 |
| publicationDate | 2007-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2007184499-A1 |
| titleOfInvention | Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system |
| abstract | The invention is directed to a method for detecting colorectal adenoma and/or colorectal carcinoma comprising the steps: a) providing an isolated sample material which has been taken from an individual, b) determining the level of transthyretin in said isolated sample material, and c)comparing the determined level of transthyretin with a reference value. The invention is further directed to a method for discriminating between colorectal adenoma and colorectal carcinoma as well as to a method for monitoring the course of colorectal adenoma and/or colorectal carcinoma and/or the treatment of colorectal adenoma and/or colorectal carcinoma. Moreover, the invention is directed to a test system and an array for use in these methods. Furthermore, the invention is directed to the use of transthyretin as a biomarker for a detection of colorectal adenoma and/or colorectal carcinoma in an individual. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116449018-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102018205-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190011359-A |
| priorityDate | 2004-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.